137 related articles for article (PubMed ID: 15647689)
1. PET imaging with F-18 fluorodeoxyglucose for primary lymphoma of bone.
Park YH; Choi SJ; Ryoo BY; Kim HT
Clin Nucl Med; 2005 Feb; 30(2):131-4. PubMed ID: 15647689
[No Abstract] [Full Text] [Related]
2. Primary bone lymphoma involving bilateral tibia.
Giardino AA; Shinagare AB; Shinagare SA; Dewar R; Weckstein D; Mauch P; Ramaiya NH; Freedman AS
Am J Hematol; 2012 Sep; 87(9):924-5. PubMed ID: 22641233
[No Abstract] [Full Text] [Related]
3. [Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients].
Oriuchi N; Higuchi T; Endo K; Tsukamoto N; Matsuda H; Kuji I; Murakami K; Nakajima K
Kaku Igaku; 2009 Jun; 46(2):96-9. PubMed ID: 19637820
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of tumor FDG transport and metabolism in primary central nervous system lymphoma using [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) kinetic analysis.
Kawai N; Nishiyama Y; Miyake K; Tamiya T; Nagao S
Ann Nucl Med; 2005 Dec; 19(8):685-90. PubMed ID: 16444994
[TBL] [Abstract][Full Text] [Related]
5. Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
Mamot C; Klingbiel D; Hitz F; Renner C; Pabst T; Driessen C; Mey U; Pless M; Bargetzi M; Krasniqi F; Gigli F; Hany T; Samarin A; Biaggi C; Rusterholz C; Dirnhofer S; Zucca E; Martinelli G
J Clin Oncol; 2015 Aug; 33(23):2523-9. PubMed ID: 26150440
[TBL] [Abstract][Full Text] [Related]
6. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
Wang J; Wang D; Zhang Q; Duan L; Tian T; Zhang X; Li J; Qiu H
J Cancer Res Clin Oncol; 2016 Apr; 142(4):859-71. PubMed ID: 26666755
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous panniculitis-like T-cell lymphoma with extracutaneous dissemination demonstrated on FDG PET/CT.
Babb A; Zerizer I; Naresh KN; Macdonald D
Am J Hematol; 2011 Apr; 86(4):375-6. PubMed ID: 21442643
[No Abstract] [Full Text] [Related]
8. 18F-FDG-PET/CT in lymphoma: two decades of experience.
Alvarez Páez AM; Nogueiras Alonso JM; Serena Puig A
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):340-9. PubMed ID: 22841459
[TBL] [Abstract][Full Text] [Related]
9. Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT.
Seshadri N; Ananthasivan R; Kavindran R; Srikanth G; Chandra S
Cancer Imaging; 2010 Oct; 10(1):194-7. PubMed ID: 20926362
[TBL] [Abstract][Full Text] [Related]
10. False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
Inoue Y; Tamaki H; Yamagami T; Iwasaki H; Nakatsuka S; Soma T
Eur J Haematol; 2007 Jul; 79(1):88-90. PubMed ID: 17532762
[No Abstract] [Full Text] [Related]
11. 18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract.
Tempescul A; Querellou S; Ianotto JC; Boisramé S; Valette G; Berthou C
Ann Hematol; 2010 Jun; 89(6):635-7. PubMed ID: 19844711
[No Abstract] [Full Text] [Related]
12. Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging.
Weijs LE; Arsos G; Baarslag HJ; Wittebol S; de Klerk JM
Eur Heart J; 2007 Nov; 28(22):2698. PubMed ID: 17567624
[No Abstract] [Full Text] [Related]
13. Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone.
Markova J; Kahraman D; Kobe C; Skopalova M; Mocikova H; Klaskova K; Dedeckova K; Eich HT; Böll B; Dietlein M; Kozak T
Leuk Lymphoma; 2012 Jan; 53(1):64-70. PubMed ID: 21740300
[TBL] [Abstract][Full Text] [Related]
14. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
[TBL] [Abstract][Full Text] [Related]
15. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
Pinnix CC; Dabaja B; Ahmed MA; Chuang HH; Costelloe C; Wogan CF; Reed V; Romaguera JE; Neelapu S; Oki Y; Rodriguez MA; Fayad L; Hagemeister FB; Nastoupil L; Turturro F; Fowler N; Fanale MA; Nieto Y; Khouri IF; Ahmed S; Medeiros LJ; Davis RE; Westin J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):113-21. PubMed ID: 25863759
[TBL] [Abstract][Full Text] [Related]
16. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
[TBL] [Abstract][Full Text] [Related]
17. Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
Pardal E; Coronado M; Martín A; Grande C; Marín-Niebla A; Panizo C; Bello JL; Conde E; Hernández MT; Arranz R; Bargay J; González-Barca E; Pérez-Ceballos E; Montes-Moreno S; Caballero MD
Br J Haematol; 2014 Nov; 167(3):327-36. PubMed ID: 25066542
[TBL] [Abstract][Full Text] [Related]
18. What is your diagnosis? Cutaneous B-cell lymphoma.
Carlson SW; Aneja S; Honda K; Cooper KD
Cutis; 2014 Nov; 94(5):217, quiz 249-51. PubMed ID: 25474456
[No Abstract] [Full Text] [Related]
19. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW
J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481
[TBL] [Abstract][Full Text] [Related]
20. Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS.
Dupuis J; Berriolo-Riedinger A; Julian A; Brice P; Tychyj-Pinel C; Tilly H; Mounier N; Gallamini A; Feugier P; Soubeyran P; Colombat P; Laurent G; Berenger N; Casasnovas RO; Vera P; Paone G; Xerri L; Salles G; Haioun C; Meignan M
J Clin Oncol; 2012 Dec; 30(35):4317-22. PubMed ID: 23109699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
